Variability of RANKL and osteoprotegerin staining in synovial tissue from patients with active rheumatoid arthritis: Quantification using color video image analysis

被引:0
作者
Crotti, TN
Ahern, MJ
Lange, K
Weedon, H
Coleman, M
Roberts-Thomson, PJ
Haynes, DR
Smith, MD [1 ]
机构
[1] Repatriat Gen Hosp, Dept Med, Adelaide, SA, Australia
[2] Flinders Med Ctr, Dept Med, Adelaide, SA, Australia
[3] Univ Adelaide, Repatriat Gen Hosp, Adelaide, SA, Australia
[4] Univ Adelaide, Rehumatol Unit, Adelaide, SA, Australia
[5] Univ Adelaide, Dept Pathol, Adelaide, SA 5005, Australia
关键词
bone; rheumatoid arthritis; osteoprotegerin; receptor activator of nuclear factor kappa B ligand; quantitative analysis; immunohistochemistry;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. To assess the interpatient, interbiopsy, and intrabiopsy variability of receptor activator of nuclear factor kappaB ligand (RANKL) and osteoprotegerin (OPG) immunostaining within synovial tissue from rheumatoid knee joints with active synovitis, using digital image analysis. Methods. Synovial biopsy specimens were obtained from patients with rheumatoid arthritis (RA) and active synovitis. Immunohistologic analysis was performed on frozen synovial tissue biopsy specimens from 6 patients using a monoclonal antibody (Mab) to detect RANKL (626) or OPG (805 or 805 1). Patients with a minimum of 4 synovial biopsies were included in the study. Sections were evaluated by computer assisted image analysis to assess between-patient, between-biopsy, and intrabiopsy variability of OPG and RANKL protein expression. The study was designed to deliberately maximize the variability. Results. Computerized image analysis of staining with Mab to RANKL and OPG revealed variance for each antibody across the 3 components of the total variability. Conclusion. Our study shows that variability in synovial immunostaining of RANKL and OPG protein is a significant and complex problem. We discuss methods to reduce this. variability and suggest that the auspices of OMERACT may be employed to advance the study of synovium in collaborative international studies.
引用
收藏
页码:2319 / 2324
页数:6
相关论文
共 34 条
[1]   A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function [J].
Anderson, DM ;
Maraskovsky, E ;
Billingsley, WL ;
Dougall, WC ;
Tometsko, ME ;
Roux, ER ;
Teepe, MC ;
DuBose, RF ;
Cosman, D ;
Galibert, L .
NATURE, 1997, 390 (6656) :175-179
[2]   THE AMERICAN-RHEUMATISM-ASSOCIATION 1987 REVISED CRITERIA FOR THE CLASSIFICATION OF RHEUMATOID-ARTHRITIS [J].
ARNETT, FC ;
EDWORTHY, SM ;
BLOCH, DA ;
MCSHANE, DJ ;
FRIES, JF ;
COOPER, NS ;
HEALEY, LA ;
KAPLAN, SR ;
LIANG, MH ;
LUTHRA, HS ;
MEDSGER, TA ;
MITCHELL, DM ;
NEUSTADT, DH ;
PINALS, RS ;
SCHALLER, JG ;
SHARP, JT ;
WILDER, RL ;
HUNDER, GG .
ARTHRITIS AND RHEUMATISM, 1988, 31 (03) :315-324
[3]  
Bresnihan B, 1998, BRIT J RHEUMATOL, V37, P636
[4]   The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts [J].
Burgess, TL ;
Qian, YX ;
Kaufman, S ;
Ring, BD ;
Van, G ;
Capparelli, C ;
Kelley, M ;
Hsu, HL ;
Boyle, WJ ;
Dunstan, CR ;
Hu, S ;
Lacey, DL .
JOURNAL OF CELL BIOLOGY, 1999, 145 (03) :527-538
[5]   Receptor activator NF-κB ligand (RANKL) expression in synovial tissue from patients with rheumatoid arthritis, spondyloarthropathy, osteoarthritis, and from normal patients:: semiquantitative and quantitative analysis [J].
Crotti, TN ;
Smith, MD ;
Weedon, H ;
Ahern, MJ ;
Findlay, DM ;
Kraan, M ;
Tak, PP ;
Haynes, DR .
ANNALS OF THE RHEUMATIC DISEASES, 2002, 61 (12) :1047-1054
[6]   Human osteoclast formation and bone resorption by monocytes and synovial macrophages in rheumatoid arthritis [J].
Fujikawa, Y ;
Sabokbar, A ;
Neale, S ;
Athanasou, NA .
ANNALS OF THE RHEUMATIC DISEASES, 1996, 55 (11) :816-822
[7]  
Gravallese EM, 2000, ARTHRITIS RHEUM, V43, P250, DOI 10.1002/1529-0131(200002)43:2<250::AID-ANR3>3.0.CO
[8]  
2-P
[9]   Osteoprotegerin expression in synovial tissue from patients with rheumatoid arthritis, spondyloarthropathies normal controls [J].
Haynes, DR ;
Barg, E ;
Crotti, TN ;
Holding, C ;
Weedon, H ;
Atkins, GJ ;
Zannetino, A ;
Ahern, MJ ;
Coleman, M ;
Roberts-Thomson, PJ ;
Kraan, M ;
Tak, PP ;
Smith, MD .
RHEUMATOLOGY, 2003, 42 (01) :123-134
[10]   Osteoprotegerin and receptor activator of nuclear factor kappaB ligand (RANKL) regulate osteoclast formation by cells in the human rheumatoid arthritic joint [J].
Haynes, DR ;
Crotti, TN ;
Loric, M ;
Bain, GI ;
Atkins, GJ ;
Findlay, DM .
RHEUMATOLOGY, 2001, 40 (06) :623-630